Finally, E2F4 has also been implicated in NER since the p130/E2F4 complex controls the expression of xeroderma pigmentosum complementation group C [53], a protein that serves as the primary initiating factor in the global genome NER pathway [91]. The gene discussed is E2F4; the disease is Xeroderma pigmentosum complementation group C.